Articles

Antidotes or Reversibility Agents – Are they Needed?

Published:

01 May 2015

Citation:

Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):1-12

How to Choose Between NOACs

Published:

01 May 2015

Citation:

Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):1-12

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):304.

Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):300–3.

Arrhythmias from the Right Ventricular Moderator Band: Diagnosis and Management

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):294–9.

High-power, Short-duration Radiofrequency Ablation for the Treatment of AF

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):265–72.

Idiopathic Left Ventricular Tachycardia Originating in the Left Posterior Fascicle

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):249–54.

Challenges Associated with Interpreting Mechanisms of AF

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):273–84.

Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):240–8.

Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):255–64.